These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29180122)

  • 21. The SAMe-TT2R2 score and quality of anticoagulation in AF: Can we predict which patient benefits from anticoagulation?
    Fauchier L; Poli D; Olshansky B
    Thromb Haemost; 2015 Oct; 114(4):657-9. PubMed ID: 26246340
    [No Abstract]   [Full Text] [Related]  

  • 22. Modified application of SAMe-TT2R2 scoring system in Asian patients with atrial fibrillation for the selection of oral anticoagulants.
    Jeon SW; Lee N; Lee KH; Ha M; Kim C; Kim YR; Yoon NS; Park HW
    Korean J Intern Med; 2024 May; 39(3):458-468. PubMed ID: 38287499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE.
    Barco S; Granziera S; Coppens M; Douxfils J; Nijkeuter M; Riva N; Vanassche T; Zhang G; Lin M; Kamphuisen PW; Cohen AT; Beyer-Westendorf J
    Thromb Haemost; 2019 Apr; 119(4):675-684. PubMed ID: 30731492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Europace; 2018 Sep; 20(9):1435-1441. PubMed ID: 29095971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis.
    van Miert JHA; Bos S; Veeger NJGM; Meijer K
    PLoS One; 2018; 13(3):e0194208. PubMed ID: 29534092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SAMe-TT
    Bernaitis N; Badrick T; Anoopkumar-Dukie S
    J Thromb Thrombolysis; 2020 Oct; 50(3):614-618. PubMed ID: 32080812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.
    Chan PH; Hai JJ; Chan EW; Li WH; Tse HF; Wong IC; Lip GY; Siu CW
    PLoS One; 2016; 11(3):e0150674. PubMed ID: 27010633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
    Lip GY; Waldo AL; Ip J; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen M; Halperin JL;
    Am J Cardiol; 2016 Dec; 118(11):1680-1684. PubMed ID: 27665206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction Score for Anticoagulation Control Quality Among Older Adults.
    Lin KJ; Singer DE; Glynn RJ; Blackley S; Zhou L; Liu J; Dube G; Oertel LB; Schneeweiss S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation.
    Pastori D; Pignatelli P; Cribari F; Carnevale R; Saliola M; Violi F; Lip GY
    Am Heart J; 2018 Jun; 200():32-36. PubMed ID: 29898846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation and stroke prevention: brief observations on the last decade.
    Lip GY
    Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):403-6. PubMed ID: 24650307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of SAMe-TT
    Hwang AY; Carris NW; Dietrich EA; Gums JG; Smith SM
    Ann Pharmacother; 2018 Nov; 52(11):1085-1090. PubMed ID: 29857777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Validity of SAMe-TT
    Alhmoud EN; Elewa H; Abdul Gelil MS; Abd El Samad OB; Elzouki AY
    Clin Appl Thromb Hemost; 2020; 26():1076029620945039. PubMed ID: 32875827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk impact of edoxaban in the management of stroke and venous thromboembolism.
    Hurst KV; O'Callaghan JM; Handa A
    Vasc Health Risk Manag; 2016; 12():329-35. PubMed ID: 27563246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score.
    Barrios V; Escobar C; Prieto L; Polo J; Muñiz J; Anguita M; H Lip GY
    Future Cardiol; 2021 Jul; 17(4):685-692. PubMed ID: 33331173
    [No Abstract]   [Full Text] [Related]  

  • 36. SAMe-TT
    Incomenoy S; Saokaew S; Poonchuay N
    Ann Pharmacother; 2024 Feb; 58(2):126-139. PubMed ID: 37125752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.
    De Caterina R; Ageno W; Boriani G; Colonna P; Ghirarduzzi A; Patti G; Rossini R; Rubboli A; Schinco P; Agnelli G
    Adv Ther; 2017 Mar; 34(3):620-637. PubMed ID: 28194578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivaroxaban: an oral factor Xa inhibitor.
    Thomas TF; Ganetsky V; Spinler SA
    Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
    Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
    Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial Fibrillation and Stroke: Making Sense of Recent Observations on Anticoagulation.
    Proietti M; Lip GY
    Cardiol Clin; 2016 May; 34(2):317-28. PubMed ID: 27150180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.